TI DEVELOP Trademark

Trademark Overview

On Thursday, March 10, 2016, a trademark application was filed for TI DEVELOP with the United States Patent and Trademark Office. The USPTO has given the TI DEVELOP trademark a serial number of 86935314. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 7, 2019. This trademark is owned by QPharma, Inc.. The TI DEVELOP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technology solution for life sciences companies, namely, providing temporary use of non-downloadable computer software for managing activities before and during clinical trial phases prior to commercialization, namely,  tracking projects, tasks, milestones, dates, budgets and regulatory items, namely, drug product information forms, good guidance practice compliance forms, regulatory and transparency reporting documents, all in the fields of  pharmaceutical and medical device product development; and services associated Technology solutions, namely, information technology (IT) consultation
ti develop

General Information

Serial Number86935314
Word MarkTI DEVELOP
Filing DateThursday, March 10, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 7, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

Disclaimer with Predetermined Text"DEVELOP"
Goods and ServicesTechnology solution for life sciences companies, namely, providing temporary use of non-downloadable computer software for managing activities before and during clinical trial phases prior to commercialization, namely,  tracking projects, tasks, milestones, dates, budgets and regulatory items, namely, drug product information forms, good guidance practice compliance forms, regulatory and transparency reporting documents, all in the fields of  pharmaceutical and medical device product development; and services associated Technology solutions, namely, information technology (IT) consultation

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 16, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameQPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960

Trademark Events

Event DateEvent Description
Monday, January 7, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 7, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, June 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 6, 2018EXTENSION 2 GRANTED
Wednesday, June 6, 2018EXTENSION 2 FILED
Wednesday, June 6, 2018TEAS EXTENSION RECEIVED
Friday, December 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2017EXTENSION 1 GRANTED
Wednesday, December 6, 2017EXTENSION 1 FILED
Wednesday, December 6, 2017TEAS EXTENSION RECEIVED
Tuesday, June 6, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 3, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2017DATA MODIFICATION COMPLETED
Tuesday, February 21, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, February 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, February 21, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 23, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 23, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 19, 2016NON-FINAL ACTION E-MAILED
Monday, September 19, 2016NON-FINAL ACTION WRITTEN
Friday, September 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 10, 2016ASSIGNED TO LIE
Thursday, September 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 15, 2016NON-FINAL ACTION E-MAILED
Wednesday, June 15, 2016NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

develop namely technology information forms product regulatory practice compliance guidance good